Given the long-life expectancy of the newborn, research aimed at improving sepsis
diagnosis and management in this population has been recognized as cost-effective, which …

A graphene oxide/nickel/platinum nanoparticle micromotor (MM)-based fluorescent
aptassay is proposed to determine interleukin-6 (IL-6) in serum samples from low-birth …

A fast and reliable OFF-ON micromotors (MM)-based aptassay for rapid, sensitive, and
accurate determination of procalcitonin (PCT) as one of the leading neonatal sepsis …

Sepsis, which includes infection followed by inflammation, is one of the leading causes of
death among neonates worldwide. The major attribute of this disease process is …

Early diagnosis of sepsis, combining blood cultures and inflammation biomarkers, continues
to be a challenge, especially in very low birth weight (VLBW) infants because of limited …

A new fluorescence micromotor-based immunoassay (FMIm) has been developed for
procalcitonin (PCT) determination as an early sepsis diagnostic analytical tool. The …

Neonatal sepsis is still a leading cause of death among newborns. Therefore a protein-
microarray for point-of-care testing that simultaneously quantifies the sepsis associated …

Sepsis is one of the deadliest health disorders in the current century due to specific
limitations in early and differential diagnosis. Therefore, early diagnosis and appropriate …

Neonatal sepsis remains a significant cause of morbidity and mortality especially in the
preterm infant population. The ability to promptly and accurately diagnose neonatal sepsis …

Sepsis is a life-threatening immune response which is caused by a wide variety of sources
and is a leading cause of mortality globally. Rapid diagnosis and appropriate antibiotic …